Markets:

Overview

News

Currencies

International

Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

37.77 -0.23 (-0.61%)

Streaming Delayed Price Updated: 9:35 AM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference

November 15, 2022

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer

November 14, 2022

From Nanobiotix S.A.

Via GlobeNewswire

Nanobiotix Posts Updated Data For Radiotherapy-Activated Cancer Therapy In Head & Neck Cancer Patients ↗

November 10, 2022

Via Benzinga

NANOBIOTIX Reports Updated Phase 1 Anti-PD-1 Combination Data That May Support the Immune Stimulation Potential of Radioenhancer NBTXR3 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer

November 10, 2022

Data to be discussed during Nanobiotix Q3 Earnings Call at 8:00AM EST

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update

November 09, 2022

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX Voting Rights and Shares Capital of the Company

November 08, 2022

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX Appoints Renowned Global Experts to Comprehensive Scientific Advisory Board for Potential First-in-Class Radioenhancer NBTXR3

November 02, 2022

Multidisciplinary board includes twelve (12) experts from the United States and Europe that will support the development of lead therapeutic candidate NBTXR3

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX to Present at the Jefferies London Healthcare Conference

October 31, 2022

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX to Announce Third Quarter 2022 Financial Results on November 9, 2022

October 27, 2022

Conference Call and Webcast to be Held at 8:00 AM ET / 2:00 PM CET on November 10, 2022

From Nanobiotix S.A.

Via GlobeNewswire

NANOBIOTIX Executes Definitive Agreement to Restructure Existing Loan With the European Investment Bank

October 18, 2022

From Nanobiotix S.A.

Via GlobeNewswire

Nanobiotix: Voting Rights and Shares Capital of the Company

October 10, 2022

From Nanobiotix

Via Business Wire

Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022

September 28, 2022

From Nanobiotix

Via Business Wire

Earnings Scheduled For September 28, 2022 ↗

September 28, 2022

Companies Reporting Before The Bell • Lilium (NASDAQ:LILM) is expected to report earnings for its second quarter.

Via Benzinga

Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022

September 22, 2022

From Nanobiotix

Via Business Wire

Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial ↗

September 22, 2022

Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell...

Via Benzinga

Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy

September 21, 2022

From Nanobiotix

Via Business Wire

Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024

September 12, 2022

From Nanobiotix

Via Business Wire

Nanobiotix: Voting Rights and Shares Capital of the Company

September 08, 2022

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 08, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 08, 2022

Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday!

Via InvestorPlace

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer

September 07, 2022

From NANOBIOTIX

Via Business Wire

NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences

September 06, 2022

From NANOBIOTIX

Via Business Wire

Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022

August 31, 2022

From NANOBIOTIX

Via Business Wire

NANOBIOTIX: Voting Rights and Shares Capital of the Company

August 09, 2022

From Nanobiotix

Via Business Wire

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 01, 2022

Via Benzinga

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗

August 01, 2022

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 29, 2022

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.

Via Benzinga

Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont

July 13, 2022

From Nanobiotix

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.